Atlas Trials

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Clinical trial NCT00838955 · TERMINATED

Trial details

NCT number
NCT00838955
Sponsor
Loyola University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin's Lymphoma
Start date
2009-01-01
Primary completion
2016-10-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.